328 related articles for article (PubMed ID: 33415161)
1. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
3. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.
Gao SS; Sun JJ; Wang X; Hu YY; Feng Q; Gou XJ
Biomed Res Int; 2020; 2020():1704960. PubMed ID: 33204683
[TBL] [Abstract][Full Text] [Related]
4. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
Yang H; Wei D; Zhang Y; Jian W
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
[TBL] [Abstract][Full Text] [Related]
5. Compound Shouwu Jiangzhi Granule regulates triacylglyceride synthesis to alleviate hepatic lipid accumulation.
Qian F; Ouyang B; Cai Z; Zhu D; Yu S; Zhao J; Wei N; Wang G; Wang L; Zhang J
Phytomedicine; 2024 Jul; 129():155691. PubMed ID: 38744232
[TBL] [Abstract][Full Text] [Related]
6. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.
Hung TC; Zhao N; Huang C; Liu S; Liu T; Huang W; Xu X; Ji ZL; Yang S
Biomed Pharmacother; 2021 Jun; 138():111408. PubMed ID: 33684693
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
PeerJ; 2022; 10():e14171. PubMed ID: 36389420
[TBL] [Abstract][Full Text] [Related]
8. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease.
Wang L; Zhi Y; Ye Y; Zhang M; Mai Z; Xia W; Song Y
J Pharm Pharmacol; 2023 Oct; 75(10):1366-1377. PubMed ID: 37467485
[TBL] [Abstract][Full Text] [Related]
10. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Li S; Wu X; Ma Y; Zhang H; Chen W
J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of Alisma orientale in treating nonalcoholic fatty liver disease].
Jiang-Dong D; Chuan-Yan L; Bing Y; Yue W; Li C; Liang F; Xiao-Bin J
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4140-4148. PubMed ID: 33164398
[TBL] [Abstract][Full Text] [Related]
12. Uncovering the protective mechanism of Taohong Siwu decoction against diabetic retinopathy via HIF-1 signaling pathway based on network analysis and experimental validation.
Wang L; Li S; Wang L; Lin K; Du J; Miao W; Zhang L
BMC Complement Med Ther; 2020 Oct; 20(1):298. PubMed ID: 33023593
[TBL] [Abstract][Full Text] [Related]
13. Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology.
Zhou W; Zhu Z; Xiao X; Li C; Zhang L; Dang Y; Ge G; Ji G; Zhu M; Xu H
Biomed Pharmacother; 2021 Nov; 143():112181. PubMed ID: 34649337
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacological analysis on the mechanism of Linggui Zhugan decoction for nonalcoholic fatty liver disease.
Gao S; Wei L; Qin Y; Zhang P; Quan T; Liang F; Huang G
Medicine (Baltimore); 2024 Mar; 103(10):e37281. PubMed ID: 38457573
[TBL] [Abstract][Full Text] [Related]
15. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
16. Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology.
Yu C; Han D; Yu J; Zhu R; Zhu C; Wang F; Zhang T
Medicine (Baltimore); 2023 Oct; 102(42):e35460. PubMed ID: 37861538
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation.
Xue H; Wang Y; Xiang H; Song Q; Zhang G; Wang J; Ge S
Evid Based Complement Alternat Med; 2022; 2022():5440347. PubMed ID: 36199550
[TBL] [Abstract][Full Text] [Related]
19. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
[TBL] [Abstract][Full Text] [Related]
20. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
